CV Sciences Inc CVSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CVSI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.03–0.06
- Bid/Ask
- $0.03 / $0.03
- Market Cap
- $5.18 Mil
- Volume/Avg
- 31,577 / 315,375
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.32
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 44
- Website
- https://www.cvsciences.com
Valuation
|
Metric
|
CVSI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.49 |
Price/Sales | 0.32 |
Price/Cash Flow | — |
Price/Earnings
CVSI
Financial Strength
|
Metric
|
CVSI
|
|---|---|
Quick Ratio | 0.38 |
Current Ratio | 1.39 |
Interest Coverage | — |
Quick Ratio
CVSI
Profitability
|
Metric
|
CVSI
|
|---|---|
Return on Assets (Normalized) | −21.87% |
Return on Equity (Normalized) | −99.05% |
Return on Invested Capital (Normalized) | −73.43% |
Return on Assets
CVSI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gdhgk | $82.1 Bil | |
MKKGY
| Merck KGaA ADR | Dqtdcd | $76.2 Bil | |
HLN
| Haleon PLC ADR | Kjwy | $38.9 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Psc | $11.3 Bil | |
VTRS
| Viatris Inc | Lxvw | $11.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Mhbt | $11.1 Bil | |
CTLT
| Catalent Inc | Bffhmk | $7.1 Bil | |
PRGO
| Perrigo Co PLC | Bhh | $4.2 Bil | |
ALKS
| Alkermes PLC | Kyrsz | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hszlk | $2.9 Bil |